Change Healthcare Acquires eRx



Gregory T. Grogan Gregory T. Grogan
Steven R. DeLott Steven R. DeLott
Lori E. Lesser Lori E. Lesser
Andrew B. Purcell Andrew B. Purcell
Andrew M. Kofsky Andrew M. Kofsky
+7

Simpson Thacher represented Change Healthcare in its acquisition of 100% of the ownership interest in eRx Network (“eRx”), a leading provider of comprehensive, innovative and secure data-driven solutions for pharmacies, for a purchase price of $212.9 million plus cash on the balance sheet. The transaction supports Change Healthcare’s commitment to focus on and invest in core aspects of the business to fuel long-term growth and advance innovation. The addition of eRx brings strategic benefits including a broader solutions portfolio to offer pharmacies, the ability to serve patients, providers and payers more comprehensively and the potential to enter new markets.

Change Healthcare (Nasdaq: CHNG) is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.

The Simpson Thacher team included Jonathan Corsico, John Dougherty and Hilary Albrecht (M&A); Gregory Grogan, Andrew Kofsky and Caitlin Lucey (Executive Compensation and Employee Benefits); Andrew Purcell and Edward Grais (Tax); Lori Lesser and Alysha Sekhon (Intellectual Property); Vanessa Burrows (Healthcare); Steven DeLott (Insurance); and Kelly Karapetyan, Kenneth Ehrhard and Nicholas Ingros (Antitrust).